T 1259/16 (Glatiramer acetate III/TEVA) of 12.09.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T125916.20170912
- Date of decision
- 12 September 2017
- Case number
- T 1259/16
- Petition for review of
- -
- Application number
- 10194363.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Process for the preparation of mixtures of trifluoroacetyl glatiramer acetate using purified hydrobromic acid
- Applicant name
- Teva Pharmaceutical Industries Ltd.
- Opponent name
- Generics [UK] Ltd (trading as Mylan)
Actavis Group ehf (opposition withdrawn)
Synthon BV
Hexal AG
G. L. Pharma GmbH (Intervener) - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 105European Patent Convention Art 114(2)European Patent Convention Art 123(2)Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Main request, auxiliary requests 1 to 32: amendments - allowable (no)
Auxiliary requests 33 to 35: admitted (no) - Catchword
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The patent is revoked.